Explore WearOptimo’s news. Here, you’ll find the latest in technology, milestones, investor insights, and company updates. Join us as we celebrate achievements, explore new horizons, and shape the future of wearable technology together. Stay informed and inspired with WearOptimo.
With lots of milestones happening locally and globally, there was no shortage of topics for conversation when founder and CEO Professor Mark Kendall appeared on 4BC Weekend Breakfast with Olympia Kwitowski.
As WearOptimo works towards the release of its hydration Microwearable sensor, The Courier-Mail has shared details of its Advanced Manufacturing Facility (AMF).
Proud day for WearOptimo, with recognition for our founder and CEO Professor Mark Kendall at the 2024 GENE Awards run by Life Sciences Queensland.
Professor Mark Kendall’s inventions have drawn attention from some of the world’s biggest names. Think the World Health Organization, the Bill & Melinda Gates Foundation and F1 Grand Prix winner Mark Webber.
WearOptimo is proud to count Mark Webber AO as an investor and strategic partner. The Formula 1 champion and endurance athlete came on board after meeting WearOptimo founder and CEO Professor Mark Kendall through a mutual association with luxury watch brand Rolex.
Cardiovascular disease is the biggest killer on the planet, claiming more than 30 million lives annually. It’s a horrifying statistic. One made even more so when you consider that all too often – especially with heart attacks – treatment could be as simple as taking an aspirin. If only the victim had more time to act.
In recognition of the start of human trials for our hydration Microwearable sensor, WearOptimo has been the subject of a special 9 News feature.
Pioneering Brisbane healthtech company WearOptimo has started clinical trials of its hydration sensor, marking a significant step in bringing this game-changing product to market.
Healthtech innovator WearOptimo and leading healthcare provider Aspen Medical have reached another significant milestone in the commercialisation of ground-breaking microwearable hydration sensors.
Aspen Medical has shown its further confidence in WearOptimo by following up its multi-million-dollar investment with the finalisation of a Strategic Collaboration Agreement and Distribution Framework Agreement.
Human trials of a microwearable sensor for the detection of dangerous dehydration levels are set to begin after the latest successful fundraising round for HealthTech firm WearOptimo. The $5 million boost will enable the company to progress its game-changing hydration monitor, through clinical trials at QUT.
A multi-million-dollar investment agreement by Aspen Medical in Queensland-based health-tech company WearOptimo, has cemented a strategic partnership between the two companies to revolutionise precision medicine globally.
We are very excited to share that WearOptimo has been awarded a $973,000 grant under the Australian Government’s Manufacturing Modernisation Fund (MMF) through the Department of Industry, Science, Energy and Resources.
World-leading, lifesaving wearable medical technology will be produced at a new Queensland facility, supported by an up to $30 million project announced today.
An Aussie inventor and entrepreneur reshaping the future of global healthcare with Microwearable technology has been recognised for the incredible impact of his work.
A key milestone on our commercial journey was reached today with the announcement of a partnership between WearOptimo and Aspen Medical.
Can Australia become a world leader in personalised medicine? Professor Mark Kendall discusses with Harvard Club of Australia.
A team of Queensland scientists is tonight developing a stick-on coronavirus warning device allowing doctors to predict which patients will need intensive care. @9NewsQueensland
In a recent announcement from Acting Health Minister Hon. Alan Tudge MP, WearOptimo received the news that it is to receive $980,000 from the Australian Federal Government as part of the BioMedTech Horizons (BMTH) program.
Professor Mark Kendall has been invited to act as co-chair of the Expert Advisory Panel of the Stem Cell Therapies Mission, helping world-class Australian researchers further investigate game-changing medical treatments for many chronic and inherited diseases.
With a growing number of MedTech companies being established in the field of innovative and revolutionary medical devices, Brisbane is quickly becoming a hub for medical engineers.
WearOptimo was included in a recent Top Story by Lynne Minion of the online newspaper Healthcare IT. The article, titled “We could lead the world”: Australia’s MTP sector shows it’s punching above its weight” showcased the 11 visionary healthcare projects selected for support in the BioMedTech Horizons funding stream, administered by MTPConnect.
The Australian National University’s first partner innovation company WearOptimo™ opened its Brisbane headquarters, expanding the national university’s presence outside of Canberra.
Today, the Australian Government announced a $150 million injection for the establishment of the Stem Cell Mission to boost health and medical research in Australia. The announcement was made by the Minister for Health Hon. Greg Hunt MP – MTPConnect was on hand for the big news and to catch up with the Mission’s Co-Chairs Professor Melissa Little and Professor Mark Kendall.
WearOptimo: transforming hydration monitoring with wearable technology and real-time app reporting, empowering you to stay refreshed and energised, wherever life takes you.
14 Hockings St, West End QLD 4101, Australia
Opening Hours:
Mon – Fri 9am to 5pm
Designed by Ailebo Consulting.